Premaitha Health (NIPT)

 

NIPT Share PerformanceMore

52 week high14.4000 06/03/17
52 week low4.2500 24/01/18
52 week change -6.2640 (-55.07%)
4 week volume16,969,550 27/01/18
price5.1110
price date1519314566
close5.2500

Media for (NIPT)

Latest NewsMore

Premaitha Health expands into Egyptian market

Prenatal testing group Premaitha Health said it had signed an agreement with a new partner to offer its test products in Eg...

Premaitha secures market entry into Egypt

RNS Number: 0580F Premaitha Health PLC 16 February 2018 Premaitha Health plc ("Premaitha" or the "Company") Premaitha secures market entry into Egypt Manchester, UK - 16 February 2018: Premaitha Health plc (AIM: NIPT), a leading international molecular diagnostics group focused on non-invasive prenatal testing ("NIPT"), announces that it has signed an...

Holding(s) in Company

Notification of major interests in shares

Thermo Fisher - issue of warrants

RNS Number: 5161E Premaitha Health PLC 12 February 2018 Premaitha Health Plc ("Premaitha" or the "Company") Thermo Fisher - issue of warrants Manchester, UK - 12 February 2018 - Premaitha Health PLC (AIM: NIPT), a leading international molecular diagnostics group focused on prenatal testing, announces that further to the notification made 12 July 2017 ...

Premaitha to attend key conferences in Middle East

Premaitha Health gets regulatory nod in Brazil

Premaitha Health said its prenatal testing product had been approved by Brazil's regulatory authority, Agncia Nacional de...

Premaitha's IONA test approved for sale in Brazil

Miscellaneous medium priority announcements

Premaitha Health gets right to appeal patent judgement

Premaitha Health said it had secured the right to appeal a judgement in its ongoing patent litigation with Illumina and oth...

Fundamental DataMore

EPS-3
Dividend yield0 %

Latest discussion posts More

  • Re: Yikes! Judge rules for Illumina

    That will depend on whether they have patents in those other countries. I'm sure they don't have a global patent. Essentially they will need to get around the negotiations ...
    23-Nov-2017
    Mr Papillon
  • Re: Yikes! Judge rules for Illumina

    Do you not think this will now be pursued by Illumina in all other jurisdictions?
    22-Nov-2017
    RichardLY
  • Re: Yikes! Judge rules for Illumina

    UK only it seems but a sad situation for women in the UK as the test will likely be withdrawn and they will have to hop on a plane to take it somewhere else. Obviously the ...
    22-Nov-2017
    Peermade

Users' HoldingsMore

Users who hold Premaitha Health also hold..

Codes & Symbols

ISINGB00BN31ZD89
SymbolsNIPT, LSE:NIPT, NIPT.L, NIPT:LN, LON:NIPT, XLON:NIPT

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account